Adrian Ciurea Selected Research

Diphtheria-Tetanus Vaccine

1/2022	Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls.
1/2019	Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Ciurea Research Topics

Disease

19	Axial Spondyloarthritis 11/2022 - 12/2013
15	Rheumatoid Arthritis 01/2022 - 05/2007
10	Ankylosing Spondylitis 01/2020 - 08/2010
5	Arthritis (Polyarthritis) 11/2022 - 08/2010
4	Necrosis 01/2022 - 11/2019
3	Psoriatic Arthritis 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2019 - 06/2017
3	Sacroiliitis 06/2017 - 08/2010
2	Infections 05/2022 - 10/2002
2	Tetanus 01/2022 - 01/2019
2	Non-Radiographic Axial Spondyloarthritis 01/2022 - 01/2015
2	Diphtheria 01/2022 - 01/2019
2	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2019
2	Virus Diseases (Viral Diseases) 08/2004 - 04/2003
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	COVID-19 05/2022
1	Post-Acute COVID-19 Syndrome 05/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Obesity 01/2017
1	Lymphoma (Lymphomas) 01/2016
1	Shoulder Fractures 03/2015
1	Spondylarthropathies 02/2015
1	Edema (Dropsy) 02/2015
1	Back Pain (Backache) 03/2014
1	Hypersensitivity (Allergy) 05/2009
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 04/2003
1	Superinfection 10/2002

Drug/Important Bio-Agent (IBA)

16	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 05/2009
9	Pharmaceutical PreparationsIBA 11/2022 - 05/2009
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 05/2007
7	Antirheumatic Agents (DMARD)IBA 11/2022 - 05/2007
7	AntibodiesIBA 05/2022 - 08/2004
6	C-Reactive ProteinIBA 01/2022 - 12/2013
4	Biological ProductsIBA 12/2021 - 05/2007
3	secukinumabIBA 11/2022 - 01/2020
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2019 - 05/2007
3	Infliximab (Remicade)FDA Link 01/2019 - 05/2009
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	Diphtheria-Tetanus VaccineIBA 01/2022 - 01/2019
2	Adalimumab (Humira)FDA Link 01/2019 - 05/2009
2	Etanercept (Enbrel)FDA Link 01/2019 - 05/2009
1	ChemokinesIBA 05/2022
1	Immunologic Factors (Immunomodulators)IBA 05/2022
1	Antiviral Agents (Antivirals)IBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	InterferonsIBA 05/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	ArginaseIBA 01/2022
1	VaccinesIBA 01/2022
1	LigandsIBA 01/2019
1	golimumab FDA Link 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	ThioredoxinsIBA 01/2018
1	GlucocorticoidsIBA 06/2017
1	Analgesics (Analgesic Drugs)IBA 06/2017
1	Anti-Citrullinated Protein AntibodiesIBA 01/2017
1	FluoridesIBA 08/2010
1	MolybdenumIBA 08/2010
1	Immunoglobulin G (IgG)IBA 04/2003
1	AutoantibodiesIBA 04/2003
1	Peptides (Polypeptides)IBA 04/2003
1	Viral AntigensIBA 04/2003
1	Immunoglobulins (Immunoglobulin)IBA 04/2003
1	Immunoglobulin M (IgM)IBA 04/2003
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2002

Therapy/Procedure

8	Therapeutics 11/2022 - 05/2007
1	Exercise Therapy (Therapy, Exercise) 04/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Injections 03/2015
1	Self-Help Devices (Assistive Technology) 01/2011